01 1Zhejiang Jingxin Pharmaceutical
01 1LEVETIRACETAM
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-07-21
Pay. Date : 2021-06-21
DMF Number : 35629
Submission : 2021-04-30
Status : Active
Type : II
20
Shaoxing Jingxin Pharmaceuticals Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LEVETIRACETAM, with a corresponding US DMF Number 35629.
Remarkably, this DMF maintains an Active status since its submission on April 30, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 21, 2021, and payment made on June 21, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
